Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A small number of people also reported changes to their heart rhythm (arrhythmias) , though none of these were considered serious
Exercise supports better weight loss outcomes and improves overall health
Current Evidence: GLP-1 Drugs and Addiction Research The potential role of GLP-1 receptor agonists in modulating addictive behaviours represents an emerging area of research, though it is important to emphasise that there is no official indication or licence for these medications in treating addiction in the UK or elsewhere
declares additional funding outside of this work by a Wellcome Trust Clinical Research Career Development Fellowship (224625/Z/21/Z)
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed for type 2 diabetes treatment in the UK
